US20240299379A1
University of Texas System
The present disclosure provides pharmaceutical compositions of clofazimine and amikacin that may be administered via inhalation. These compositions may be used to treat one or more diseases or disorders such as a bacterial infection or other lung diseases or disorders. These compositions may be …